A Clinical Trial of Pembrolizumab in Patients With Hepatitis B Virus-related Hepatocellular Carcinoma, With Parallel Study on Baseline and Serial Change in the Immune Environment
Phase of Trial: Phase II
Latest Information Update: 21 May 2018
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 10 May 2018 Status changed from not yet recruiting to recruiting.
- 07 Feb 2018 New trial record
- 04 Feb 2018 Planned initiation date changed from 1 Feb 2018 to 1 Mar 2018.